<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Alloimmune <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> react with <z:chebi fb="1" ids="16247">phospholipids</z:chebi> and are an epiphenomenon of an <z:e sem="disease" ids="C0009450" disease_type="Disease or Syndrome" abbrv="">infectious disease</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Most autoimmune <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> recognise <z:chebi fb="0" ids="16247">phospholipid</z:chebi>-protein complexes or proteins, such as beta2 <z:chebi fb="2" ids="17089">glycoprotein</z:chebi> I or prothrombin and are related to the clinical features of the <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain><z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">Lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi>, anticardiolipin antibodies, antiprothrombin, and anti-beta2 <z:chebi fb="2" ids="17089">glycoprotein</z:chebi> I antibodies were studied in 61 human <z:hpo ids='HP_0002721'>immunodeficiency</z:hpo> virus (HIV) patients, 55 syphilis patients, and 45 selected patients with <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain><z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">Lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> was present in 72% of HIV and 81% of <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> patients </plain></SENT>
<SENT sid="4" pm="."><plain>None of the <z:e sem="disease" ids="C0039128" disease_type="Disease or Syndrome" abbrv="">syphilis</z:e> patients had <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> </plain></SENT>
<SENT sid="5" pm="."><plain>Anticardiolipin antibodies were found at comparable prevalence in the three groups (HIV 67%, <z:e sem="disease" ids="C0039128" disease_type="Disease or Syndrome" abbrv="">syphilis</z:e> 67%, <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> 84%) </plain></SENT>
<SENT sid="6" pm="."><plain>HIV had more frequently anti-beta2 <z:chebi fb="2" ids="17089">glycoprotein</z:chebi> I (13%) and antiprothrombin (12%) antibodies than <z:e sem="disease" ids="C0039128" disease_type="Disease or Syndrome" abbrv="">syphilis</z:e> (0 and 4%, respectively), but significantly less than <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> (61 and 40%, respectively) </plain></SENT>
<SENT sid="7" pm="."><plain>Autoimmune <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> in HIV without clinical features of <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> might be a reflex of the immunological chaos and/or the constant antigenic virus stimulus </plain></SENT>
</text></document>